CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,147,980 | +6.6% | 53,000 | 0.0% | 0.01% | +20.0% |
Q4 2022 | $1,076,430 | -20.8% | 53,000 | 0.0% | 0.01% | -28.6% |
Q3 2022 | $1,359,000 | -78.5% | 53,000 | -80.1% | 0.01% | -75.0% |
Q2 2022 | $6,333,000 | +430.4% | 266,300 | +402.5% | 0.03% | +600.0% |
Q1 2022 | $1,194,000 | +13.8% | 53,000 | 0.0% | 0.00% | +100.0% |
Q4 2021 | $1,049,000 | +1465.7% | 53,000 | +1458.8% | 0.00% | – |
Q3 2021 | $67,000 | -88.3% | 3,400 | -85.8% | 0.00% | -100.0% |
Q1 2021 | $571,000 | -58.8% | 24,000 | -54.7% | 0.00% | -75.0% |
Q4 2020 | $1,386,000 | – | 53,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |